Pfizer and GSK to battle for share of new RSV vaccine market

Published on June 16, 2023

With both GSK and Pfizer recently gaining FDA approval for their respective respiratory syncytial virus (RSV) vaccines, the stakes are high for competition in the sector.

Continue reading on website
Other news

Beacon Therapeutics enters gene therapy arena with $120m launch

June 16, 2023
Beacon Therapeutics has kickstarted its entry into the gene therapy field with a $120m Series A financing.The British investment trust Syncona Limited launched the new ophthalmic gene therapy company by combining Applied Genetic Technologies Corporation’s (AGTC’s) late-stage X-linked retinitis pigmentosa (XLRP) programme with two proprietary preclinical programmes.The funding, with participation f

Abu Dhabi DoH signs new deal to accelerate development in life sciences

June 16, 2023
The Department of Health Abu Dhabi (DoH) has made a declaration of collaboration with Mass General Brigham’s (MGB) International Center for Genetic Disease (iCGD) to advance life sciences.The deal is aimed at advancing life sciences across three strategic areas: clinical and translational research, capacity building and technology transfer, and in the area of commercialisation.Benefiting from Abu